Llwytho...
Chimeric antigen receptors: driving immunology towards synthetic biology
The advent of second generation CARs and the CD19 paradigm have ushered a new therapeutic modality in oncology. In contrast to earlier forms of adoptive cell therapy, which were based on the isolation and expansion of naturally occurring T cells, CAR therapy is based on the design and manufacture of...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Curr Opin Immunol |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5520666/ https://ncbi.nlm.nih.gov/pubmed/27372731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2016.06.004 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|